GlassScriptPhysician profile
Muhammad Umer Farooq
NPI 1083023683
$1,041.84
in general payments reported to CMS, 2019-2025
9 companies · $691 in 2025
The $691 reported for 2025 was more than what 79% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $32.42 · 2022: $277 · 2023: $41.11 · 2025: $691.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $521 · Travel and Lodging: $211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $521.46 |
| Travel and Lodging | $210.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $303.65 | 2023-2025 | Impella |
| Philips North America LLC | $210.84 | 2025 | Igt Devices Undivided |
| Abbott Laboratories | $172.31 | 2022 | |
| Penumbra, INC. | $143.00 | 2025 | Indigo System |
| Astrazeneca Pharmaceuticals LP | $94.43 | 2020-2022 | |
| Boston Scientific Corporation | $58.30 | 2025 | Opticross, Filterwire Ez, Synergy |
| Janssen Pharmaceuticals, INC | $24.82 | 2022 | |
| Amgen INC. | $17.98 | 2020 | |
| Shockwave Medical, INC | $16.51 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Umer Farooq listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.